Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/26 17:22 | 2/17/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 11 | S.d | -16,732 | 123.94 | 0 | -135 | 121 | D | |||||||||||||||
2/18/26 17:11 | 2/17/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Dickinson Andrew D | CA | O | CFO | 19 | S.d | -58,086 | 98.21 | 0 | -591 | 173 | D | |||||||||||||||
2/6/26 16:22 | 2/5/26 | GILD | Health | BioPrd | Biological Products, (No Diag | O'Day Daniel Patrick | CA | DO | CB,CEO | 11 | S.d | -43,665 | 135.91 | 0 | -321 | 620 | D | |||||||||||||||
1/21/26 16:26 | 1/20/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Bluestone Jeffrey | CA | D | 4 | S.d | -2,412 | 110.70 | 0 | -22 | 9 | D | ||||||||||||||||
12/1/25 16:54 | 11/26/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Kramer Kelly A. | CA | D | 1 | S.dm | -713 | 127.11 | 0 | -6 | 1 | D | ||||||||||||||||
11/13/25 19:36 | 11/12/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Telman Deborah H | CA | O | EVP,Corp | 1 | S.d | -6,590 | 122.85 | 0 | -54 | 44 | D | |||||||||||||||
11/29/24 20:10 | 11/27/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Parsey Merdad | CA | O | Chief Me | 2 | S.d | -17,435 | 91.86 | 0 | -190 | 100 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |